ORAL HYGIENE, PERIODONTAL STATUS AND QUALITY OF LIFE
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorAbant Izzet Baysal University
About this trial
This cross-sectional study aims to evaluate the relationship between oral hygiene habits, periodontal status, and oral health-related quality of life in adult individuals. A total of approximately 160 participants attending the Department of Periodontology will be included. Periodontal status will be assessed using standard clinical parameters, including probing depth, clinical attachment loss, bleeding on probing, and plaque index. In addition, the Periodontal Inflamed Surface Area (PISA) will be calculated to quantify inflammatory burden. Oral health-related quality of life will be evaluated using the OSHIP-Perio questionnaire, a validated patient-reported outcome measure specific to periodontal conditions. The study will investigate the association between clinical periodontal findings, oral hygiene practices, and quality of life outcomes. The findings are expected to provide a comprehensive understanding of both clinical and patient-centered aspects of periodontal disease and contribute to improved individualized treatment approaches.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Individuals aged 18 years and older
Patients presenting to the Department of Periodontology Individuals willing to participate and provide informed consent
Disqualifiers
Use of antibiotics or anti-inflammatory drugs within the last 3 months
History of periodontal treatment within the last 6 months
Pregnancy or lactation
Individuals unable to complete the questionnaire
Trial population
The study population will consist of individuals aged 18 years and older presenting to the Department of Periodontology at Bolu Abant İzzet Baysal University Faculty of Dentistry. Participants will be classified into periodontally healthy, gingivitis, and periodontitis groups according to the 2017 classification of periodontal diseases and conditions.
Trial design
Design model
Other
Time perspective
Cross-sectional
Treatments tested in this trial
Oral Health Assessment and OSHIP-Perio Questionnaire
Other interventionParticipants will undergo a comprehensive periodontal clinical examination, including assessment of probing pocket depth (PPD), clinical attachment loss (CAL), bleeding on probing (BOP), and plaque and gingival indices. In addition, participants will complete the OSHIP-Perio questionnaire to evaluate the impact of periodontal status on oral health-related quality of life. No invasive or therapeutic intervention will be performed as part of this study.
Treatment groups
160 Participants
are divided into 3 treatment groupsGroup A: PERIODONTITIS PATIENTS1 intervention
Group B: GINGIVITIS PATIENTS1 intervention
Group C: periodontally healthy individuals1 intervention
Trial outcomes
Primary outcomes
1
Oral health-related quality of life (OSHIP-Perio score)
The primary outcome is the Oral and Systemic Health Impact Profile for Periodontal Disease (OSHIP-Perio) total score obtained from a 21-item questionnaire assessing the impact of periodontal status on oral health-related quality of life.
Time frame
Baseline (single visit)Secondary outcomes
1
Probing Pocket Depth (PPD)
Probing pocket depth (PPD) will be measured in millimeters using a calibrated periodontal probe at six sites per tooth.
Time frame
Baseline (single visit)2
Periodontitis Stage (2017 Classification)
Periodontitis stage will be determined according to the 2017 World Workshop Classification of Periodontal Diseases, based on clinical attachment loss, radiographic bone loss, and tooth loss.
Time frame
Baseline (single visit)3
Clinical Attachment Level (CAL)
Clinical attachment level (CAL) will be measured in millimeters using a periodontal probe at six sites per tooth.
Time frame
Baseline (single visit)4
Bleeding on Probing (BOP)
Bleeding on probing (BOP) will be assessed as the presence or absence of bleeding within 15 seconds after probing and recorded as percentage (%).
Time frame
Baseline (single visit)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov